Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Cough is among the most common complaints for which patients seek medical attention. Leading cough researcher Peter V. Dicpinigaitis, M.D., Professor of Clinical Medicine at New York's Albert Einstein College of Medicine, recently conducted a new cough challenge study among adults, whose results were first presented at the European Respiratory Society International Congress in September 2014.

13 Oct 2014

Viewpoints: Effects of health law; conquering Ebola

In case you don't follow me on Twitter, here it is: The Affordable Care Act has already helped slow the rate of growth in health-care costs across the board, putting more money in Americans' pockets and bringing down projected deficits even as millions more people sign up for health insurance and receive access to Medicaid.

13 Oct 2014

New study on global burden of venous thromboembolism

A study on the global burden of venous thromboembolism—when a dangerous clot forms in a blood vessel—found that annual incidences range from 0.75 to 2.69 per 1,000 individuals in the population.

13 Oct 2014

Pneumococcal vaccine prevents illness, reduces severe antibiotic-resistant infections in young children

The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek 2014.

12 Oct 2014

Isis Pharmaceuticals provides update on Phase 2 clinical studies of ISIS-SMN Rx in children with SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical studies of ISIS-SMN Rx in infants and children with spinal muscular atrophy at the 19th International World Muscle Society (WMS) Congress in Berlin, Germany.

10 Oct 2014

Views on giving flu shot to younger children

It's a common question parents ask themselves this time of year: Does my child really need a flu shot? Though the flu may seem harmless, the truth is on average 20,000 children age 5 and younger are hospitalized due to flu symptoms each year.

10 Oct 2014

First study of promising Ebola vaccine commenced in West Africa

Professor Myron M. Levine, MD, Director of the Center for Vaccine Development at the University of Maryland School of Medicine, and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, The Center for Vaccine Development of Mali and the Ministry of Health of Mali, have begun a clinical trial in health care workers (and other front-line workers) to evaluate a promising experimental Ebola vaccine.

10 Oct 2014

Study suggests that college athletes who play contact sports more likely to carry MRSA

Even if they don't show signs of infection, college athletes who play football, soccer and other contact sports are more likely to carry the superbug methicillin-resistant Staphylococcus aureus (MRSA), suggests a study on MRSA and athletes, which is being presented at IDWeek 2014-.

10 Oct 2014

DU/ER Denim introduces first ever jean with radioactive cell phone protection

Avoid the electromagnetic danger of keeping your cellphone in your pocket; denim brand launches first ever jean with radioactive cell phone protection –to protect your vital organs.

9 Oct 2014

MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities.

9 Oct 2014

Study shows rats, mice perform similarly in cognitive tests; offers implications for cognition research

It's one of those ideas that seems to make perfect sense: the bigger the brain, the more intelligent the creature.

9 Oct 2014

Minimally invasive valve-repair procedures offer hope for patients who have heart-valve problems

Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral valve insufficiency. The later turned her life into a battle for breath, eliminating almost all activities and even making sleep a struggle. She couldn't sleep for more than 20-minutes at a time without waking in a fit of coughing. Thanks to a leading-edge procedure performed at UT Southwestern Medical Center, Mrs. Henderson is now breathing - and sleeping - easy.

9 Oct 2014

Viewpoints: Walmart's cuts in insurance grow from health law; online marketplace still lacks transparency

Wal-Mart gave lawmakers a concise lesson in economics Tuesday when it disclosed that it would no longer offer health insurance to yet more of its part-time employees. ... I'll just argue that what we're seeing is the entirely predictable result of the employer mandate in the 2010 Patient Protection and Affordable Care Act -- a mandate, by the way, that Wal-Mart lobbied for. The company was offering health benefits for most employees at the time, and may simply have been trying to force its competitors to do the same (Jon Healey, 10/7).

9 Oct 2014

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

The federal government has awarded a patent to the Translational Genomics Research Institute and Northern Arizona University for a test that can detect — and assist in the treatment of — the H1N1 pandemic flu strain.

9 Oct 2014

Columbia Nursing researcher suggests ways to prevent nursing home infections

Nursing home infection rates are on the rise, a study from Columbia University School of Nursing found, suggesting that more must be done to protect residents of these facilities from preventable complications. The study, which examined infections in U.S. nursing homes over a five-year period, found increased infection rates for pneumonia, urinary tract infections (UTIs), viral hepatitis, septicemia, wound infections, and multiple drug-resistant organisms (MDROs).

8 Oct 2014

As U.S. bolsters defenses against Ebola, price tag grows

President Barack Obama vows national defense against the disease but reminds Americans that the human toll in Africa is also worthy of their support. Administration weighs tighter screening for international travelers.

8 Oct 2014

U-M researchers propose new ways to fight sepsis

A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.

8 Oct 2014

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.

8 Oct 2014

Study: H7N9 flu vaccine combined with adjuvant is essential to promote protective immune response

A large, NIH-sponsored clinical trial of an experimental H7N9 avian influenza vaccine found an immune response that was believed to be protective in 59 percent of study participants who received two injections of the inactivated vaccine at the lowest dosage tested when mixed with an adjuvant – a component that boosts the body's immune response and enhances the effectiveness of inactivated influenza vaccines.

8 Oct 2014

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).

8 Oct 2014

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Viewpoints: Effects of health law; conquering Ebola

New study on global burden of venous thromboembolism

Pneumococcal vaccine prevents illness, reduces severe antibiotic-resistant infections in young children

Isis Pharmaceuticals provides update on Phase 2 clinical studies of ISIS-SMN Rx in children with SMA

Views on giving flu shot to younger children

First study of promising Ebola vaccine commenced in West Africa

Study suggests that college athletes who play contact sports more likely to carry MRSA

DU/ER Denim introduces first ever jean with radioactive cell phone protection

MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

Study shows rats, mice perform similarly in cognitive tests; offers implications for cognition research

Minimally invasive valve-repair procedures offer hope for patients who have heart-valve problems

Viewpoints: Walmart's cuts in insurance grow from health law; online marketplace still lacks transparency

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

Columbia Nursing researcher suggests ways to prevent nursing home infections

As U.S. bolsters defenses against Ebola, price tag grows

U-M researchers propose new ways to fight sepsis

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Study: H7N9 flu vaccine combined with adjuvant is essential to promote protective immune response

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in